DXCM Financial Facts
Development grant and other revenue: 0Selling, general and administrative: 75.7M
See Full Income Statement
Total liabilities: 100.1M
Other assets: 1.5M
See Full Balance Sheet
DexCom, Inc. (DXCM) Earnings
|
Expand Research on DXCM
| Next EPS Date | 4/25/24 | EPS Growth Rate | +58.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +31.1% | Revenue Growth Rate | +22.7% |
| Average % Move 1-Wk after EPS | -0.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $0.27 | N/A | N/A | $909.93M | = | N/A | N/A | ||
| 2/8/24 | Q423 | $0.50 | $0.43 | +$0.07 | $1.03B | $1.02B | = |  | | Details | |
| 10/26/23 | Q323 | $0.50 | $0.34 | +$0.16 | $975M | $939.19M | = | | | Details | |
| 7/27/23 | Q223 | $0.34 | $0.23 | +$0.11 | $871.3M | $841.18M | = | | | Details | |
| 4/27/23 | Q123 | $0.17 | $0.15 | +$0.02 | $741.5M | $720.67M | = | | | Details | |
| 2/9/23 | Q422 | $0.34 | $0.27 | +$0.07 | $815.2M | $809.35M | = | | | Details | |
| 10/27/22 | Q322 | $0.28 | $0.24 | +$0.04 | $769.6M | $751.74M | = | | | Details | |
| 7/28/22 |  |
Q222 | $0.17 | $0.19 | -$0.02 | $696.2M | $700.45M | = | | | Details |
